Literature DB >> 18180978

Polyglandular autoimmunity with macrophagic myofasciitis.

Brett J Theeler1, Novae B Simper, John P Ney.   

Abstract

We report a man with chronic fatigue, multiple autoimmune disorders, and a muscle biopsy consistent with macrophagic myofasciitis. This rare and recently described muscle disorder is seen in patients exposed to vaccinations with aluminum hydroxide adjuvant. This case highlights the relationship between macrophagic myofasciitis and autoimmunity.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18180978     DOI： 10.1007/s10067-007-0793-9

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN： 0770-3198            Impact factor:   2.980


  8 in total

1.  Macrophagic myofasciitis associated with inclusion body myositis: a report of three cases.

Authors:  P Chérin; D Menard; P Mouton; J F Viallard; C Le Hello; F J Authier; R K Ghérardi; M Coquet; S Herson; J P Leroi
Journal:  Neuromuscul Disord       Date:  2001-07       Impact factor: 4.296

2.  Macrophagic myofasciitis unrelated to vaccination.

Authors:  J H Park; K S Na; Y W Park; S S Paik; D H Yoo
Journal:  Scand J Rheumatol       Date:  2005       Impact factor: 3.641

3.  Macrophagic myofasciitis lesions assess long-term persistence of vaccine-derived aluminium hydroxide in muscle.

Authors:  R K Gherardi; M Coquet; P Cherin; L Belec; P Moretto; P A Dreyfus; J F Pellissier; P Chariot; F J Authier
Journal:  Brain       Date:  2001-09       Impact factor: 13.501

4.  Atypical presentation of macrophagic myofasciitis 10 years post vaccination.

Authors:  Aisling M Ryan; Niamh Bermingham; Hugh J Harrington; Catherine Keohane
Journal:  Neuromuscul Disord       Date:  2006-09-26       Impact factor: 4.296

5.  Macrophagic myofasciitis.

Authors:  P Cherin; R K Gherardi
Journal:  Curr Rheumatol Rep       Date:  2000-06       Impact factor: 4.592

6.  Central nervous system disease in patients with macrophagic myofasciitis.

Authors:  F J Authier; P Cherin; A Creange; B Bonnotte; X Ferrer; A Abdelmoumni; D Ranoux; J Pelletier; D Figarella-Branger; B Granel; T Maisonobe; M Coquet; J D Degos; R K Gherardi
Journal:  Brain       Date:  2001-05       Impact factor: 13.501

7.  Macrophagic myofasciitis: an emerging entity. Groupe d'Etudes et Recherche sur les Maladies Musculaires Acquises et Dysimmunitaires (GERMMAD) de l'Association Française contre les Myopathies (AFM).

Authors:  R K Gherardi; M Coquet; P Chérin; F J Authier; P Laforêt; L Bélec; D Figarella-Branger; J M Mussini; J F Pellissier; M Fardeau
Journal:  Lancet       Date:  1998-08-01       Impact factor: 79.321

Review 8.  Glutamic acid decarboxylase autoantibodies and neurological disorders.

Authors:  M Vianello; B Tavolato; B Giometto
Journal:  Neurol Sci       Date:  2002-10       Impact factor: 3.307
  8 in total
  4 in total

1.  Macrophagic myofasciitis: characterization and pathophysiology.

Authors:  R K Gherardi; F J Authier
Journal:  Lupus       Date:  2012-02       Impact factor: 2.911

Review 2.  Biopersistence and brain translocation of aluminum adjuvants of vaccines.

Authors:  Romain Kroum Gherardi; Housam Eidi; Guillemette Crépeaux; François Jerome Authier; Josette Cadusseau
Journal:  Front Neurol       Date:  2015-02-05       Impact factor: 4.003

3.  Morin Stain Detects Aluminum-Containing Macrophages in Macrophagic Myofasciitis and Vaccination Granuloma With High Sensitivity and Specificity.

Authors:  Rati Chkheidze; Dennis K Burns; Charles L White; Diana Castro; Julie Fuller; Chunyu Cai
Journal:  J Neuropathol Exp Neurol       Date:  2017-04-01       Impact factor: 3.685

4.  Macrophagic myofasciitis and subcutaneous pseudolymphoma caused by aluminium adjuvants.

Authors:  Hyunhee Kim; Ka Young Lim; Jeongwan Kang; Jin Woo Park; Sung-Hye Park
Journal:  Sci Rep       Date:  2020-07-16       Impact factor: 4.379
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.